Alglucosidase Alfa Pompe Safety Sub-Registry

Inclusion Criteria

• •The patient must be enrolled in the Pompe Registry;
• •Provide a signed patient information and authorization form;
• •Have a confirmed diagnosis of Pompe disease (confirmation of diagnosis is defined as documented GAA enzyme deficiency from any tissue source and/or documentation of 2 GAA gene mutations);
• •Be naïve to and plan to be treated with alglucosidase alfa at or prior to enrollment, or are being treated with alglucosidase alfa.